Nalaganje...
Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease with no clear etiology and a paucity of therapeutic options. Nintedanib (previously known as BIBF 1120) is a tyrosine kinase receptor antagonist which inhibits a number of key receptors, including those for platelet...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3693725/ https://ncbi.nlm.nih.gov/pubmed/23818761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S38833 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|